AR035489A1 - 4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6,-tetrahidropiridinas sustituidas, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estas sustancias para la preparacion de medicamentos - Google Patents

4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6,-tetrahidropiridinas sustituidas, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estas sustancias para la preparacion de medicamentos

Info

Publication number
AR035489A1
AR035489A1 ARP010104225A ARP010104225A AR035489A1 AR 035489 A1 AR035489 A1 AR 035489A1 AR P010104225 A ARP010104225 A AR P010104225A AR P010104225 A ARP010104225 A AR P010104225A AR 035489 A1 AR035489 A1 AR 035489A1
Authority
AR
Argentina
Prior art keywords
phenyl
preparation
medicines
cyclohexyl
compounds
Prior art date
Application number
ARP010104225A
Other languages
English (en)
Inventor
Michael Sattlegger
Boris Chizh
Claudia Hinze
Sundermann Bernd Dr
Angelika Kerwer-Thomas
Gisela Henn
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR035489A1 publication Critical patent/AR035489A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6-tetrahidro-piridinas sustituidas, de la fórmula general (1) en la cual R1 representa alquilo C1-5 (ramificado o no ramificado), halógeno (excepto 4-Cl), O-alquilo C1-5 (ramificado o no ramificado), S-alquilo C1-5 (ramificado o no ramificado), y/o sus sales con ácidos fisiológicamente tolerables, procedimientos para su preparación, medicamentos que contienen estos compuestos y su uso para la preparación de medicamentos.
ARP010104225A 2000-09-08 2001-09-05 4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6,-tetrahidropiridinas sustituidas, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estas sustancias para la preparacion de medicamentos AR035489A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10044649A DE10044649A1 (de) 2000-09-08 2000-09-08 Substituierte 4-Phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine

Publications (1)

Publication Number Publication Date
AR035489A1 true AR035489A1 (es) 2004-06-02

Family

ID=7655648

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104225A AR035489A1 (es) 2000-09-08 2001-09-05 4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6,-tetrahidropiridinas sustituidas, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estas sustancias para la preparacion de medicamentos

Country Status (17)

Country Link
US (1) US7034041B2 (es)
EP (1) EP1315700B1 (es)
JP (1) JP2004508353A (es)
AR (1) AR035489A1 (es)
AT (1) ATE344244T1 (es)
AU (2) AU2002210486B2 (es)
CA (1) CA2421835A1 (es)
DE (2) DE10044649A1 (es)
DK (1) DK1315700T3 (es)
ES (1) ES2275740T3 (es)
HU (1) HUP0303676A2 (es)
MX (1) MXPA03001540A (es)
NZ (1) NZ525144A (es)
PE (1) PE20020369A1 (es)
PL (1) PL366065A1 (es)
PT (1) PT1315700E (es)
WO (1) WO2002020481A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE10360793A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US20060063802A1 (en) 2004-03-29 2006-03-23 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US9072662B2 (en) 2004-03-29 2015-07-07 Auris Medical Ag Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8268866B2 (en) 2004-03-29 2012-09-18 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US20090246255A1 (en) * 2005-09-28 2009-10-01 Thomas Meyer Pharmaceutical Compositions for the Treatment of Inner Ear Disorders
US20150044200A1 (en) 2011-12-12 2015-02-12 Otolanum Ag Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system
CN107001347B (zh) 2015-10-15 2019-09-24 江苏恒瑞医药股份有限公司 氧杂螺环类衍生物、其制备方法及其在医药上的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29137A (id) * 1998-07-27 2001-08-02 Schering Corp Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1

Also Published As

Publication number Publication date
DE10044649A1 (de) 2002-07-04
CA2421835A1 (en) 2003-03-07
US20030225116A1 (en) 2003-12-04
HUP0303676A2 (hu) 2004-03-01
NZ525144A (en) 2006-01-27
DK1315700T3 (da) 2007-02-19
PT1315700E (pt) 2007-01-31
DE50111385D1 (de) 2006-12-14
AU1048602A (en) 2002-03-22
JP2004508353A (ja) 2004-03-18
EP1315700B1 (de) 2006-11-02
US7034041B2 (en) 2006-04-25
MXPA03001540A (es) 2003-06-06
PE20020369A1 (es) 2002-05-18
WO2002020481A3 (de) 2002-07-18
ES2275740T3 (es) 2007-06-16
WO2002020481A2 (de) 2002-03-14
ATE344244T1 (de) 2006-11-15
AU2002210486B2 (en) 2006-06-01
PL366065A1 (en) 2005-01-24
EP1315700A2 (de) 2003-06-04

Similar Documents

Publication Publication Date Title
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
ECSP055746A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
AR058433A1 (es) Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso
UY29437A1 (es) Nuevos antagonistas de cgrp
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR0307886B1 (pt) produto refratário que contém mais de 85% de zircÈnia (zro2).
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
MX9204625A (es) Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva.
AR046970A1 (es) Esteres de fosfato de florfenicol
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
UY26513A1 (es) Nuevas piperidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparación.
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
ES2167931T3 (es) Derivados bifenilicos sustituidos por un radical aromatico o heteroaromatico y composiciones farmaceuticas y cosmeticas que los contienen.
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
UY26675A1 (es) Sales de imidazo-3-aminas e imidazo-5-aminas bicíclicas n-aciladas y sus productos de adicción con ácidos, procedimientos para su preparación y medicamentos que contienen estos compuestos
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
AR035489A1 (es) 4-fenil-1-(1-fenil-ciclohexil)-1,2,3,6,-tetrahidropiridinas sustituidas, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de estas sustancias para la preparacion de medicamentos
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
AR030662A1 (es) Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
CO4940435A1 (es) Sal de hemisulfato del (1s,4r)-cis-4-[2-amino-6- (ciclopropilamino)-9h-purin-9-il]-2-ciclopenten-1-metanol o un solvato del mismo
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.

Legal Events

Date Code Title Description
FC Refusal
FA Abandonment or withdrawal